AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $57.38
- 52-wk high
- $82.22
- High
- $58.35
- 52-wk low
- $39.12
- Low
- $56.81
- Prev close
- $58.27
- Mkt cap
- $18.79B
- Volume
- 3.54M
- Fwd P/E
- 9.1x
- Beta
- 0.35
- Div yield
- 7.07%
- P/S
- 0.6x
- P/B
- 1.8x
- Profit margin
- -1.1%
- Op margin
- +17.9%
- ROE
- -2.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LYB filings
Are insiders buying or selling LyondellBasell Industries NV (LYB) stock?
Neither. LyondellBasell Industries NV (LYB) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded LYB recently?
None. No member of Congress disclosed a LYB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this LYB smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- MG
Man Group
$166.5M
added
- QR
Qube Research
$149.3M
bought
Sells/Trims (1)
- MI
Millennium
$164.0M
trimmed
What insiders are doing
Sells (1)
- KJ
Kaplan Jeffrey A
$742K
sold
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in LYB right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 20.8% above what analysts expected.
Earnings per share
$3.56 expected
Reports Oct 30, 2026, in 29 days
Estimates as of Sep 30, 2026
EPS expected
$2.16 to $3.03
Revenue expected
13 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.73B | $7.09B | $7.20B | $9.18B |
| Cost of what it sold | $6.82B | $6.63B | $6.50B | $7.14B |
| Gross profit | $906.0M | $460.0M | $701.0M | $2.04B |
| What it spent | ||||
| Research and development | $34.0M | $35.0M | $36.0M | $34.0M |
| Sales and admin | $401.0M | $373.0M | $411.0M | $387.0M |
| Other operating costs | $1.20B | $92.0M | $15.0M | $74.0M |
| Total operating expenses | $1.64B | $500.0M | $462.0M | $495.0M |
| What was left | ||||
| Operating profit | -$731.0M | -$40.0M | $239.0M | $1.54B |
| Interest on debt | $130.0M | $107.0M | $130.0M | $125.0M |
| Profit before tax | -$848.0M | -$147.0M | $137.0M | $808.0M |
| Tax | -$19.0M | -$7.0M | -$2.0M | $236.0M |
| Net profit | -$892.0M | -$140.0M | $125.0M | $559.0M |
| EBITDA | -$368.0M | $345.0M | $617.0M | $1.29B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace